34 results
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
14 Nov 23
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
12:00am
) is ongoing
-Presented eight posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress including data on proprietary RiboCAR
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
10 Aug 23
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
8:13am
and durability at the 2023 American Society of Gene and Cell Therapy (ASGCT) Spotlight on Immuno-Oncology
LONDON and NEW YORK, August 10, 2023 (GLOBE
8-K
EX-99.1
mst80
11 May 23
MeiraGTx Reports First Quarter 2023 Financial and Operational Results
8:12am
8-K
EX-99.1
0rooj5e3kksl
10 Nov 22
Entry into a Material Definitive Agreement
8:07am
8-K
EX-99.1
xmar1 s6labzxl6j
10 Nov 21
MeiraGTx Reports Third Quarter 2021 Financial and Operational Results
8:18am
8-K
EX-99.1
yad5garc 8z
11 Mar 21
MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
8:14am
8-K
EX-99.1
tdj608vkfryv 4nga2
6 Aug 20
MeiraGTx Reports Second Quarter 2020 Financial Results
8:15am